Latest Breaking News On - Phase 2 revive trial - Page 1 : comparemela.com

Marina Kremyanskaya, MD, PhD, discusses the safety profile and future implications of rusfertide in the treatment of patients with phlebotomy-dependent polycythemia vera, as seen in the phase 2 REVIVE trial.

Marina kremyanskayaIcahn school of medicineIcahn schoolMount sinaiInpatient oncology unitMount sinai hospitalThe tisch cancer institute at mount sinaiOnclive tvMyeloproliferative neoplasmsPolycythemia veraPhase 2 revive trial